Official recall notice

FDA DrugClass IINotable

Ascend Laboratories LLC Recall (May 2026)

Product: Ascend Laboratories, LLC, Metoprolol Succinate Extended-Release Tablets, USP, 25 mg* Rx Only, Manufactured by: Alkem Laboratories Ltd., India, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054, NDC 67877-590-01.

Recall date
2026-05-20
Category
Drug
FDA class
Class II

Why it was recalled

Hazard

Failed Dissolution Specifications

One email a week when there are new recalls. Confirm by email; unsubscribe anytime.

Product description

Failed Dissolution Specifications

Verify with the official notice →
Share:

Related Recalls

2026-08-05 · FDA_DRUG
FDA Recall: Dabigatran Etexilate Capsules, 75 mg, 30-count (3x10) blister pack further packaged in a carton, Rx
Ascend Laboratories, LLC
2026-08-05 · FDA_DRUG
FDA Recall: Dabigatran Etexilate Capsules, 75 mg, 60-count (6x10)blister pack further packaged in a carton, Rx o
Ascend Laboratories, LLC
2026-08-05 · FDA_DRUG
FDA Recall: Dabigatran Etexilate Capsules, 150 mg, 60-count (6x10) blister pack further packaged in a carton, Rx
Ascend Laboratories, LLC
2026-07-29 · FDA_DRUG
FDA Recall: Dabigatran etexilate Capsules, 150 mg, 20-count carton (2x10), Rx only, Manufactured by: Alkem Labor
Ascend Laboratories, LLC